ArticleInternal medicine journal2025
Outcome measures after attending a specialist-led diabetes mellitus model of care in regional Victoria, Australia.
Article in Internal medicine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProviding diabetes mellitus care to regional Australia remains a significant challenge due to limited access, workforce and travel. While primary care is essential, some patients require specialised care that necessitates adapted models of care.
aimsThe study assessed the effect on diabetes mellitus metrics in patients attending a multidisciplinary centre in regional Victoria. We assessed changes in HbA1c over 6 months. Secondary outcomes included biometrics, drug combinations, insulin initiation and the proportion achieving diabetes care targets.
methodsWe performed a longitudinal cohort study for all adult patients receiving multidisciplinary diabetes care at South West Healthcare between 1 July 2020 and 30 June 2022. Participants who had followed up over 6 months at three-monthly intervals (V1, V2 and V3) were included, excluding haemodialysis or transplant care or failure to attend three visits.
resultsWe assessed 90 participants with a balanced demographic with a generally low comorbidity burden. There was a significant decrease in HbA1c at 3 months (OR = -1.2 (95% CI: -1.6 to -1.1), P < 0.001) and 6 months (OR = -1.8 (95% CI: -2.2 to -1.5), P < 0.001) for all groups. Attendance within the cohort significantly increased for multidisciplinary services, including optometry, cDNE, dietetics and podiatry, but no change in drug regimens or insulin initiation.
conclusionThis study highlights the impact of an adapted model of care for diabetes mellitus at South West Healthcare, focusing on a regional population. Among 90 patients over 6 months, there was a significant reduction in HbA1c levels and improved multidisciplinary engagement. This approach has successfully increased access to specialist and multidisciplinary diabetes care in rural areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.